CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.

被引：0
|
作者：
Moreton, P [1 ]
Morgan, GJ [1 ]
Cooke, G [1 ]
Hillmen, P [1 ]
Child, T [1 ]
机构：
[1] Gen Infirm, Acad Unit Haematol & Oncol, Leeds LS1 3EX, W Yorkshire, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4998
引用
收藏
页码：310B / 310B
页数：1
相关论文
共 50 条
  • [1] Oral idarubicin, vincristine and dexamethason (VID) in the treatment of multiple myeloma.
    Glasmacher, A
    Haferlach, T
    Gorschluter, M
    Mezger, J
    Maintz, C
    Clemens, MR
    Ko, Y
    Kleinschmidt, R
    Gieseler, F
    BLOOD, 1997, 90 (10) : 4130 - 4130
  • [2] PAD is a highly effective regimen for the treatment of patients with relapsed refractory multiple myeloma.
    Delforge, Michel
    Janssens, Ann
    Dierickx, Dann
    Maertens, Johan
    Theunissen, Koen
    Vandenberghe, Peter
    Verhoef, Gregor
    BLOOD, 2006, 108 (11) : 363B - 363B
  • [3] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A
  • [4] Liposomal doxorubicin in the treatment of multiple myeloma.
    Jajeh, A
    Zalzaleh, G
    Koko, I
    BLOOD, 2003, 102 (11) : 380B - 380B
  • [5] Multiple myeloma.
    Raje N.
    Anderson K.C.
    Current Treatment Options in Oncology, 2000, 1 (1) : 73 - 82
  • [6] Pulsed oral dexamethasone in relapsed and refractory multiple myeloma.
    Smith, AG
    Crofts, SE
    WhatelySmith, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 310 - 310
  • [7] CAD (Cyclophosphamide, Adriamycin®, Dexamethasone):: A safe and effective regimen in multiple myeloma.
    Szelényi, H
    Kreuser, ED
    Menssen, HD
    Knauf, WU
    Thiel, E
    BLOOD, 1998, 92 (10) : 283B - 283B
  • [8] Sphingolipids as a novel target for the treatment of multiple myeloma.
    Kang, Yubin
    Venketa, Jagadish Kummetha
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Low dose thalidomide for the treatment of multiple myeloma.
    Bittencourt, R
    Almeida, AD
    Friederich, JR
    Fernande, F
    Fogliatto, L
    Paz, A
    Astigarraga, C
    Leugeur, D
    Silla, L
    BLOOD, 2005, 106 (11) : 370B - 370B
  • [10] Chronic hemodialysis as an adjunct treatment for multiple myeloma.
    Shah, S
    Parisi, C
    Ackad, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) : A47 - A47
12345